Moreover, the risk of developing severe COVID-19 is increased in hypertensive individuals compared with normotensives, possibly due to enhanced Angiotensin-converting enzyme-2 (ACE-2) receptor expression [1–8]. This evidence concerns the gene ACE2 and COVID-19.